Wuhan Keqian Biology Co.,Ltd

SHSE:688526 Voorraadrapport

Marktkapitalisatie: CN¥6.7b

Wuhan Keqian BiologyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Wuhan Keqian BiologyLtd has a total shareholder equity of CN¥3.9B and total debt of CN¥58.3M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.4B and CN¥573.3M respectively. Wuhan Keqian BiologyLtd's EBIT is CN¥241.8M making its interest coverage ratio -7.1. It has cash and short-term investments of CN¥1.1B.

Belangrijke informatie

1.5%

Verhouding schuld/eigen vermogen

CN¥58.28m

Schuld

Rente dekkingsratio-7.1x
ContantCN¥1.07b
AandelenCN¥3.86b
Totaal verplichtingenCN¥573.29m
Totaal activaCN¥4.43b

Recente financiële gezondheidsupdates

Recent updates

The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

Oct 09
The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Sep 26
These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

Aug 20
Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Jun 26
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Apr 08
Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Apr 05
Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Mar 20
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Analyse van de financiële positie

Kortlopende schulden: 688526's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥485.3M).

Langlopende schulden: 688526's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥88.0M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 688526 has more cash than its total debt.

Schuld verminderen: 688526's debt to equity ratio has increased from 0% to 1.5% over the past 5 years.

Schuldendekking: 688526's debt is well covered by operating cash flow (627.1%).

Rentedekking: 688526 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven